Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Belinda Lennox has been given the title of Professor of Psychiatry in the 2019 Recognition of Distinction Exercise at the University of Oxford.

Professor Lennox is the first female Professor of Psychiatry at the University of Oxford. She is also an Honorary Consultant Psychiatrist in the Early Intervention in Psychosis (EIP) service for Oxford Health NHS Foundation Trust.

Since joining the Department in 2012, Professor Lennox has led research into the causes and treatment of psychotic illness. Her current research is in the autoimmune basis of psychosis and she jointly runs a clinic with neurologists to assess and treat people with autoimmune psychosis, as well as, running a clinical trial to test out this new approach.

 

I'm so delighted to be given this title and to be the first female professor of psychiatry in the Department of Psychiatry. I'm looking forward to carrying on with my research and improving diagnosis and treatment for those with serious mental illness. I hope that there will be many women joining me soon, as being a clinical academic psychiatrist is certainly the best job in the world! - Professor Belinda Lennox.

 

For more information about Professor Lennox and her work.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Improving Experiences of People with Serious Mental Health Problems

Mental Health

A project led by Professor Kam Bhui and Dr Roisin Mooney, University of Oxford, will focus on reducing the number of people admitted or readmitted to compulsory care under the Mental Health Act. This is one of four new research projects funded by the National Institute for Health Research (NIHR) with the aim to improve patient experiences and outcomes under the Mental Health Act.

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

SSRI Treatment in Young People with Depression and Anxiety

Anxiety Depression Mental Health

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.